Little; Melvyn
Patent Applications and Registrations
Patent applications and USPTO patent grants for Little; Melvyn.The latest application filed is for "trifunctional antigen-binding molecule".
Company Profile
3.23.28
- Little; Melvyn - St. Peter-Ording DE
- Little; Melvyn - Neckargemund DE
Patent Activity
| Patent | Date |
|---|---|
| Trifunctional Antigen-binding Molecule App 20220048994 - Little; Melvyn ; et al. | 2022-02-17 |
| Bispecific CD33 and CD3 Binding Proteins App 20210024654 - Ellwanger; Kristina ; et al. | 2021-01-28 |
| Bispecific CD33 and CD3 binding proteins Grant 10,626,190 - Ellwanger , et al. | 2020-04-21 |
| Antibody binding sites specific for EGFRvIII Grant 10,273,309 - Ellwanger , et al. | 2019-04-30 |
| Antigen-binding Molecule And Uses Thereof App 20180346590 - Little; Melvyn ; et al. | 2018-12-06 |
| Bispecific CD33 and CD3 Binding Proteins App 20180291113 - ELLWANGER; Kristina ; et al. | 2018-10-11 |
| CD3 binding domains Grant 10,066,015 - Zhukovsky , et al. September 4, 2 | 2018-09-04 |
| Bispecific CD33 and CD3 binding proteins Grant 9,803,029 - Ellwanger , et al. October 31, 2 | 2017-10-31 |
| Anti-CD16 binding molecules Grant 9,701,750 - Hoffmann , et al. July 11, 2 | 2017-07-11 |
| Trifunctional Antigen-binding Molecule App 20170037128 - LITTLE; Melvyn ; et al. | 2017-02-09 |
| Compounds For Use In The Treatment Of Alzheimer's Disease App 20160361413 - Weiss; Stefan Franz Thomas ; et al. | 2016-12-15 |
| Bispecific CD33 and CD3 Binding Proteins App 20160194409 - ELLWANGER; Kristina ; et al. | 2016-07-07 |
| Compounds for use in the treatment of Alzheimer's disease Grant 9,365,647 - Weiss , et al. June 14, 2 | 2016-06-14 |
| ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII App 20160152728 - ELLWANGER; Kristina ; et al. | 2016-06-02 |
| Cd3 Binding Domains App 20160039934 - ZHUKOVSKY; Eugene ; et al. | 2016-02-11 |
| Bispecific CD33 and CD3 Binding Proteins App 20160002333 - ELLWANGER; Kristina ; et al. | 2016-01-07 |
| Bispecific CD33 and CD3 binding proteins Grant 9,212,225 - Ellwanger , et al. December 15, 2 | 2015-12-15 |
| Antigen-binding Molecule And Uses Thereof App 20150225484 - LITTLE; Melvyn ; et al. | 2015-08-13 |
| Anti-cd16 Binding Molecules App 20150218275 - Hoffmann; Karin ; et al. | 2015-08-06 |
| Anti-CD16 binding molecules Grant 9,035,026 - Hoffmann , et al. May 19, 2 | 2015-05-19 |
| Compounds For Use In The Treatment Of Alzheimer's Disease App 20140220041 - Weiss; Stefan Franz Thomas ; et al. | 2014-08-07 |
| Antigen-binding Molecule And Uses Thereof App 20130189263 - LITTLE; Melvyn ; et al. | 2013-07-25 |
| Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIa Grant 8,455,627 - Linhard , et al. June 4, 2 | 2013-06-04 |
| Multivalent antibody constructs Grant 8,148,496 - Little , et al. April 3, 2 | 2012-04-03 |
| Antigen-Binding Molecule And Uses Thereof App 20110206672 - Little; Melvyn ; et al. | 2011-08-25 |
| Antibody Of Human Origin For Inhibiting Thrombocytes Aggregation App 20110165175 - Linhard; Claudia ; et al. | 2011-07-07 |
| Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types Grant 7,901,677 - Little , et al. March 8, 2 | 2011-03-08 |
| Antibody of human origin specifically binding to activated state of platelet integrin receptor GPIIb/IIIa Grant 7,812,136 - Buettner , et al. October 12, 2 | 2010-10-12 |
| Multivalent Antibody Constructs App 20100099853 - Little; Melvyn ; et al. | 2010-04-22 |
| Anti-cd16 binding molecules App 20090214574 - Hoffmann; Karin ; et al. | 2009-08-27 |
| Multivalent antibody constructs Grant 7,507,796 - Little , et al. March 24, 2 | 2009-03-24 |
| Antibody Combination Useful For Tumor Therapy App 20080145362 - Kipriyanov; Sergey ; et al. | 2008-06-19 |
| Multivalent antibody contructs App 20070031436 - Little; Melvyn ; et al. | 2007-02-08 |
| Multivalent antibody constructs Grant 7,129,330 - Little , et al. October 31, 2 | 2006-10-31 |
| Antibody combination useful for tumor therapy App 20050176934 - Kipriyanov, Sergey ; et al. | 2005-08-11 |
| Bispecific anti-cd19x anti-cd16 antibodies and uses thereof App 20050089519 - Kipriyanov, Sergey ; et al. | 2005-04-28 |
| Dimeric and multimeric antigen binding structure App 20050079170 - Le Gall, Fabrice ; et al. | 2005-04-14 |
| Anti-cd3 single-chain antibodies having human cmu3 and cmu4 domains App 20040175786 - Choi, Ingrid ; et al. | 2004-09-09 |
| Phagemid for antibody screening Grant 6,730,483 - Breitling , et al. May 4, 2 | 2004-05-04 |
| Phagemid for antibody screening App 20020160463 - Breitling, Frank ; et al. | 2002-10-31 |
| Preparation and use of gene banks of human antibodies ("human-antibody libraries") Grant 6,319,690 - Little , et al. November 20, 2 | 2001-11-20 |
| Phagemid library for antibody screening Grant 6,127,132 - Breitling , et al. October 3, 2 | 2000-10-03 |
| Phagemid for antibody screening Grant 5,985,588 - Breitling , et al. November 16, 1 | 1999-11-16 |
| Phagemid for antibody screening Grant 5,849,500 - Breitling , et al. December 15, 1 | 1998-12-15 |
| Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries") Grant 5,840,479 - Little , et al. November 24, 1 | 1998-11-24 |
Company Registrations
| SEC | 0001619853 | Little Melvyn |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 